Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Bratton

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Thorax|January 12, 2017
Obstructive sleep apnoea and quality of life in Ehlers-Danlos syndrome: a parallel cohort studyThomas Gaisl, Cecilia Giunta, Daniel J Bratton, et al.
ERJ Open Research|September 23, 2020
Response to mepolizumab treatment is sustained across 4-weekly dosing periodsIan D Pavord, Eugene R Bleecker, Roland Buhl, et al.
The Journal of Allergy and Clinical Immunology|February 22, 2020
Severe eosinophilic asthma with nasal polyposis: A phenotype for improved sinonasal and asthma outcomes with mepolizumab therapyPeter Howarth, Geoffrey Chupp, Linda M Nelsen, et al.
The Lancet. Respiratory Medicine|July 1, 2017
Reappraisal of the clinical effect of mepolizumab - Authors' replyGeoffrey L Chupp, Eric S Bradford, Frank C Albers, et al.
The Lancet. Respiratory Medicine|December 3, 2014
Sleep apnoea in the elderly - authors' replyAlison McMillan, Daniel J Bratton, Rita Faria, et al.
The Lancet. Respiratory Medicine|April 12, 2017
Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trialGeoffrey L Chupp, Eric S Bradford, Frank C Albers, et al.
The Lancet. Respiratory Medicine|August 31, 2014
Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (PREDICT): a 12-month, multicentre, randomised trialAlison McMillan, Daniel J Bratton, Rita Faria, et al.
Health Technology Assessment (Winchester, England)|June 12, 2015
A multicentre randomised controlled trial and economic evaluation of continuous positive airway pressure for the treatment of obstructive sleep apnoea syndrome in older people: PREDICTAlison McMillan, Daniel J Bratton, Rita Faria, et al.
OTO Open|December 22, 2023
Patient-Reported Outcome Measures for Severe Recurrent Bilateral Nasal Polyps: Psychometric Evaluation and Content ValidityAdam Gater, Chloe Tolley, Rebecca Williams-Hall, et al.
Journal of Lower Genital Tract Disease|July 6, 2018
Help for Future Research: Lessons Learned in Trial Design, Recruitment, and Delivery From the "hELP" StudyRosalind C Simpson, Ruth Murphy, Daniel J Bratton, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Thorax|January 12, 2017
Obstructive sleep apnoea and quality of life in Ehlers-Danlos syndrome: a parallel cohort studyThomas Gaisl, Cecilia Giunta, Daniel J Bratton, et al.
ERJ Open Research|September 23, 2020
Response to mepolizumab treatment is sustained across 4-weekly dosing periodsIan D Pavord, Eugene R Bleecker, Roland Buhl, et al.
The Journal of Allergy and Clinical Immunology|February 22, 2020
Severe eosinophilic asthma with nasal polyposis: A phenotype for improved sinonasal and asthma outcomes with mepolizumab therapyPeter Howarth, Geoffrey Chupp, Linda M Nelsen, et al.
The Lancet. Respiratory Medicine|July 1, 2017
Reappraisal of the clinical effect of mepolizumab - Authors' replyGeoffrey L Chupp, Eric S Bradford, Frank C Albers, et al.
The Lancet. Respiratory Medicine|December 3, 2014
Sleep apnoea in the elderly - authors' replyAlison McMillan, Daniel J Bratton, Rita Faria, et al.
The Lancet. Respiratory Medicine|April 12, 2017
Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trialGeoffrey L Chupp, Eric S Bradford, Frank C Albers, et al.
The Lancet. Respiratory Medicine|August 31, 2014
Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (PREDICT): a 12-month, multicentre, randomised trialAlison McMillan, Daniel J Bratton, Rita Faria, et al.
Health Technology Assessment (Winchester, England)|June 12, 2015
A multicentre randomised controlled trial and economic evaluation of continuous positive airway pressure for the treatment of obstructive sleep apnoea syndrome in older people: PREDICTAlison McMillan, Daniel J Bratton, Rita Faria, et al.
OTO Open|December 22, 2023
Patient-Reported Outcome Measures for Severe Recurrent Bilateral Nasal Polyps: Psychometric Evaluation and Content ValidityAdam Gater, Chloe Tolley, Rebecca Williams-Hall, et al.
Journal of Lower Genital Tract Disease|July 6, 2018
Help for Future Research: Lessons Learned in Trial Design, Recruitment, and Delivery From the "hELP" StudyRosalind C Simpson, Ruth Murphy, Daniel J Bratton, et al.
Pageof 5